Why Big Pharma sees the abortion drug legal fight as a grave business risk

Why Big Pharma sees the abortion drug legal fight as a grave business risk

Subscribe to the Magazine

View this as website

Why Big Pharma sees the abortion drug legal fight as a grave business risk

Why Big Pharma sees the abortion drug legal fight as a grave business risk

One year after the nation learned of the Supreme Court's intent to peel back federal protections for abortions via a leaked draft opinion, a new legal fight over the approval of a common abortion drug has ignited condemnation from nearly every corner of the pharmaceutical industry.

Read the full story here.

Vermont becomes first state to allow nonresidents to use assisted suicide

Latest News in US Healthcare

Vermont becomes first state to allow nonresidents to use assisted suicide

By Misty Severi

Get Byron York’s Daily Memo into your inbox.

Click here to sign up to start receiving it now.

Comments